2013
DOI: 10.1371/journal.pone.0080995
|View full text |Cite|
|
Sign up to set email alerts
|

Molecular Markers for Granulovacuolar Degeneration Are Present in Rimmed Vacuoles

Abstract: BackgroundRimmed vacuoles (RVs) are round-oval cytoplasmic inclusions, detected in muscle cells of patients with myopathies, such as inclusion body myositis (IBM) and distal myopathy with RVs (DMRV). Granulovacuolar degeneration (GVD) bodies are spherical vacuoles containing argentophilic and hematoxyphilic granules, and are one of the pathological hallmarks commonly found in hippocampal pyramidal neurons of patients with aging-related neurodegenerative diseases, such as Alzheimer's disease and Parkinson's dis… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
6
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 48 publications
0
6
0
Order By: Relevance
“…3A and C). The appearance of vacuoles is an age- and disease-related change observed in neurons in aged rodents (de Estable-Puig and Estable-Puig, 1975) and post-mortem human tissue from various dementias (Ball and Lo, 1977; Nakamori et al , 2013). Granulovacuolar degeneration bodies, a hallmark of Alzheimer’s disease, are late-stage autophagocytic vacuoles, the accumulation of which may relate to incomplete autophagy (Funk et al , 2011).…”
Section: Resultsmentioning
confidence: 99%
“…3A and C). The appearance of vacuoles is an age- and disease-related change observed in neurons in aged rodents (de Estable-Puig and Estable-Puig, 1975) and post-mortem human tissue from various dementias (Ball and Lo, 1977; Nakamori et al , 2013). Granulovacuolar degeneration bodies, a hallmark of Alzheimer’s disease, are late-stage autophagocytic vacuoles, the accumulation of which may relate to incomplete autophagy (Funk et al , 2011).…”
Section: Resultsmentioning
confidence: 99%
“…However, in the GVB model in cultured neurons EEA1 was absent from GVBs – whereas early endosomes were clearly detected in a punctate staining pattern –, indicating a more prominent involvement of late than early stage endosomal proteins in GVBs. In line with this, also the membrane-associated protein Flotillin-1 that localizes to the plasma membrane as well as the membrane of late endosomes and lysosomes, co-localizes with GVBs in the human and mouse brain [ 95 , 148 ]. Flotillin-1 is additionally being used as an exosomal membrane marker, raising the possibility that some GVBs undergo exocytosis, although GVBs are typically not observed in association with the plasma membrane and to date experimental data supporting GVB release is lacking.…”
Section: Gvb Identitymentioning
confidence: 87%
“…This suggest that selective targeting or degradation mechanisms are at play in GVBs. Furthermore, a plethora of other proteins involved in various cellular processes have been found in GVBs (for a tabular overview of GVB-localizing proteins discovered till 2016 see [ 65 ]; in our literature search, we additionally came across publications reporting GVB localization in tissue for PKR [ 135 ], phosphorylated p300 [ 5 ], PICALM [ 2 ], annexin2 [ 95 ], LRRK2 [ 95 ] and reticulon-3 [ 36 ] and publications after 2016 showed the GVB localization of TMEM230 [ 119 ], Dvl3 [ 93 ], rapsyn [ 93 ], APC [ 93 ], PrP [ 142 ], Golgin A4 [ 69 ], phosphorylated (S65) ubiquitin [ 45 ], SSBP1 [ 45 ], nucleolin [ 38 ], SIL1 [ 73 ], NF-κB [ 145 ], GM130 [ 148 ], β-COP [ 148 ], matrin-3 [ 148 ], G3BP [ 148 ] and immunoreactivity of GVBs for an anti-sialic acid antibody [ 94 ] (for phospho-specific antibodies see Table 3 )). In conclusion, regardless of the presence of proteolytic activity markers, the GVB core harbors a variety of proteins, including various markers of cellular stress and potentially harmful proteins.…”
Section: Gvb Identitymentioning
confidence: 99%
“…The Funding Statement for this article [ 1 ] states that the study received funding from the Smoking Research Foundation, which according to [ 2 ] has received financial support from the tobacco industry. In light of this issue the PLOS ONE article [ 1 ] does not comply with the journal’s policy on Funding from Tobacco Companies [ 3 ] which was implemented in 2010. Therefore, the PLOS ONE Editors issue this Expression of Concern.…”
mentioning
confidence: 99%
“…We regret that this concern was not identified and addressed prior to the article’s [ 1 ] publication.…”
mentioning
confidence: 99%